The Great Britain is witnessing a noticeable surge in interest surrounding entheogenic substances. Beyond the common use of psilocybin and LSD, researchers and enthusiasts are increasingly focused on less-charted territories, particularly the copyright compound and the budding cannabinoid, cannab